Frequent chromosomal gains in recurrent juvenile nasopharyngeal angiofibroma

Cancer Genetics and Cytogenetics

Volumn 175, Issue 2, 2007, Pages 138-143

  Heinrich, Ulf Rüdiger ^a   Brieger, Jürgen ^a   Gosepath, Jan ^a   Wierzbicka, Magorzata ^b   Sokolov, Maxim ^c   Roth, Yehudah ^c   Szyfter, Witold ^b   Bittinger, Fernando ^a   Mann, Wolf J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c WOLFSON MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADOLESCENT; ADULT; ANEUPLOIDY; ARTICLE; AUTOSOME; CHROMOSOME; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; JUVENILE NASOPHARYNGEAL ANGIOFIBROMA; MALE; NASOPHARYNX FIBROMA; NASOPHARYNX TUMOR; ONCOGENE; ONSET AGE; PRIORITY JOURNAL; SCHOOL CHILD; TUMOR RECURRENCE; X CHROMOSOME; Y CHROMOSOME;

ADOLESCENT; ADULT; ANGIOFIBROMA; CHILD; CHROMOSOME ABERRATIONS; GENOMICS; HUMANS; MALE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NUCLEIC ACID HYBRIDIZATION;

EID: 34249784513     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.02.010     Document Type: Article

References (28)

1. Batsakis J.G. Tumors of the head and neck: clinical and pathological considerations. 2nd ed. (1979), Williams & Wilkins, Baltimore, MD pp. 296-300
2. Amedee R., Klaeyle D., Mann W., and Geyer H. Juvenile angiofibromas: a 40-year surgical experience. ORL J Otorhinolaryngol Relat Spec 51 (1989) 56-61
3. Kühn U.M., Mann W.J., and Amedee R.G. Endonasal approach for nasal and paranasal sinus tumor removal. ORL J Otorhinolaryngol Relat Spec 63 (2001) 366-371
4. Mann W.J., Jecker P., and Amedee R.G. Juvenile angiofibromas: Changing surgical concept over the last 20 years. Laryngoscope 114 (2004) 291-293
5. Schick B., and Kahle G. Radiological findings in angiofibroma. Acta Radiol 41 (2000) 585-593
6. Schiff M., Gonzalez A.M., Ong M., and Baird A. Juvenile nasopharyngeal angiofibroma contain an angiogenic growth factor: basic FGF. Laryngoscope 102 (1992) 940-945
7. Dillard D.G., Cohen C., Muller S., Del Gaudio J., Reichman O., Parrish B., Rackley D., and Gal A.A. Immunolocalization of activated transforming growth factor beta 1 in juvenile nasopharyngeal angiofibroma. Arch Otolaryngol Head Neck Surg 126 (2000) 723-725
8. Brieger J., Wierzbicka M., Sokolow M., Roth Y., Szyfter W., and Mann W.J. Vessel density, proliferation, and immunolocalization of vascular endothelial growth factor in juvenile nasopharyngeal angiofibromas. Arch Otolaryngol Head Neck Surg 130 (2004) 727-731
9. Hwang H.C., Mills S.E., Patterson K., and Gown A.M. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol 11 (1998) 1122-1126
10. Schick B., Brunner C., Praetorius M., Plinkert P.K., and Urbschat S. First evidence of genetic imbalances in angiofibromas. Larygoscope 112 (2002) 397-401
11. Schick B., Rippel C., Brunner C., Jung V., Plinkert P.K., and Urbschat S. Numerical sex chromosome aberrations in juvenile angiofibromas: genetic evidence for an androgen-dependent tumor?. Oncol Rep 10 (2003) 1251-1255
12. Brunner C., Urbschat S., Jung V., Praetorius M., Schick B., and Plinkert P.K. Chromosomal alterations in juvenile angifibromas. [In German]. HNO 51 (2003) 981-985
13. Abraham S.C., Montgomery E.A., Giardiello F.M., and Wu T.T. Frequent β-catenin mutations in juvenile nasopharyngeal angiofibromas. Am J Pathol 158 (2001) 1073-1078
14. Schick B., Wemmert S., Jung V., Steudel W.-I., Montenarh M., and Urbschat S. Genetic heterogeneity of the MYC oncogene in advanced juvenile angiofibromas. Cancer Genet Cytogenet 164 (2006) 25-31
15. Brieger J., Jacob R., Riazimand H.S., Essig E., Heinrich U.R., Bittinger F., and Mann W.J. Chromosomal aberrations in premalignant and malignant squamous epithelium. Cancer Genet Cytogenet 144 (2003) 148-155
16. Teixeira M.R. Combined classical and molecular cytogenetic analysis of cancer. Eur J Cancer 38 (2002) 1580-1584
17. Lessler M.A. The nature and specificity of the Feulgen reaction. Arch Biochem 32 (1951) 42-54
18. Böcking A. DNA measurements. When and why?. In: Wied G.L., Keebler C.M., and Rosenthal D.L. (Eds). Compendium on quality assurance, proficiency testing and workload limitations in clinical cytology (1995), Tutorials of Cytology, Chicago 170-188
19. Entrez Genome database [Internet]. Bethesda, MD: National Center for Biotechnology Information. Updated December 22, 2005. Available at: http://www.ncbi.nlm.nih.gov/entrez/.
20. Oxford G., and Theodorescu D. Ras superfamily monomeric G proteins in carcinoma cell motility. Cancer Lett 189 (2003) 117-128
21. Cheng K.W., Lahad J.P., Gray J.W., and Mills G.B. Emerging role of RAB GTPases in cancer and human disease. Cancer Res 65 (2005) 2516-2519
22. Calvo A., Xiao N., Kang J., Best C.J.M., Leiva I., Emmert-Buck M.R., Jorcyk C., and Green J.E. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorgenicity and down-regulation of selenoprotein-P in mouse and human tumors. Cancer Res 62 (2002) 5325-5335
23. Croizet-Berger K., Daumerie C., Couvreur M., Courtoy P.J., and van den Hove M.-F. The endocytic catalysts, Rab5a and Rab7, are tandem regulators of thyroid hormone production. Proc Natl Acad Sci U S A 99 (2002) 8277-8282
24. Mor O., Nativ O., Stein A., Novak L., Lehavi D., Shiboleth Y., Rozen A., Berent E., Brodsky L., Feinstein E., Rahav A., Morag K., Rothenstein D., Persi N., Mor Y., Skaliter R., and Regev A. Molecular analysis of transitional cell carcinoma using cDNA microarray. Oncogene 22 (2003) 7702-7710
25. Cao J., Gao T., Stanbridge E.J., and Irie R. RBP1L1, a retinoblastoma-binding protein-related gene encoding an antigenic epitope abundantly expressed in human carcinomas and normal testis. J Natl Cancer Inst 93 (2001) 1159-1165
26. Jones G.C., DeSanto L.W., Bremer J.W., and Neel H.B. Juvenile angiofibromas: behavior and treatment of extensive and residual tumors. Arch Otolaryngol Head Neck Surg 112 (1986) 1191-1193
27. Braakhuis B.J., Tabor M.P., Kummer J.A., Leemans C.R., and Brakenhoff R.H. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63 (2003) 1727-1730
28. Fisch U. The infratemporal fossa approach for nasopharyngeal tumors. Laryngoscope 93 (1983) 36-44